Andreas Puschmann
31 – 40 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease : Long-Term Observation and Implications of Clinical Subtypes
- Contribution to journal › Article
-
Mark
A relatively common hypomorphic variant in WARS2 causes monogenic disease
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Clinical classification systems and long-term outcome in mid- and late-stage Parkinson’s disease
- Contribution to journal › Article
-
Mark
MAP3K6 Mutations in a Neurovascular Disease Causing Stroke, Cognitive Impairment, and Tremor
- Contribution to journal › Article
-
Mark
Throat-Clearing Vocalizations in Primary Brain Calcification Syndromes
- Contribution to journal › Letter
- 2020
-
Mark
New generation genetic testing entering the clinic
- Contribution to journal › Article
-
Mark
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
- Contribution to journal › Article
-
Mark
Do variants in IRF2BPL cause both neurological disorders and keratoconus 8?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Abstracts of the IAPRD XXV World Congress on Parkinson's Disease and Related Disorders, 2020. Congress theme : Diagnosing and treating movement disorders in the era of personalized medicine
- Contribution to journal › Debate/Note/Editorial
-
Mark
Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke
- Contribution to journal › Article
